Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial. (nature.com)

Authors: Shitara K … Lee KW Journal: Nature Medicine Published: 2026-09-24 DOI: https://doi.org/10.1038/s41591-026-04700-3